trial
as of 2026-07-01Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
NCTId NCT06340789
at a glance
Phase 2 · Recruiting
Enrollment 90 (estimated)
Sponsored by National Cheng-Kung University Hospital
Primary completion 2028-04-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Recruiting
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2021-11-18
Primary completion
2028-04-30
Eligibility
ALL · 20 Years · 55 Years
Interventions & indications
Sponsors
National Cheng-Kung University HospitalLead Sponsor
Investigators
1
Yen-Kuang Yang, DrStudy Director
Sites
1 total
Chiayi City, Taiwan
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
90
Phase
PHASE2
Primary Completion Date
2028-04-30
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person